Last reviewed · How we verify
Crow-Fukase (POEMS) syndrome
Approved treatments
- Thalomid · Ann & Robert H Lurie Children's Hospital of Chicago
- Thalomid · Bristol-Myers Squibb
Thalomid works by inhibiting the production of tumor necrosis factor, a protein that promotes inflammation and tumor growth.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Crow-Fukase (POEMS) syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Crow-Fukase (POEMS) syndrome treatment landscape brief
- Crow-Fukase (POEMS) syndrome treatment updates RSS
Frequently asked questions about Crow-Fukase (POEMS) syndrome
What drugs treat Crow-Fukase (POEMS) syndrome?
Tracked treatments include Thalomid.
What is the treatment for Crow-Fukase (POEMS) syndrome?
Standard treatment for Crow-Fukase (POEMS) syndrome includes Thalomid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Crow-Fukase (POEMS) syndrome patent cliff · Crow-Fukase (POEMS) syndrome CI report
- Treatment: Thalomid · Ann & Robert H Lurie Children's Hospital of Chicago
- Treatment: Thalomid · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing